Antimicrobial Susceptibility Testing Market by Product Type (Automated Products, Consumables, Manual Products), Method (Agar Dilution, Disks Diffusion, ETEST), Type, Application, End-User - Global Forecast 2024-2030

Antimicrobial Susceptibility Testing Market by Product Type (Automated Products, Consumables, Manual Products), Method (Agar Dilution, Disks Diffusion, ETEST), Type, Application, End-User - Global Forecast 2024-2030

The Antimicrobial Susceptibility Testing Market size was estimated at USD 3.81 billion in 2023 and expected to reach USD 4.02 billion in 2024, at a CAGR 5.83% to reach USD 5.67 billion by 2030.

Antimicrobial susceptibility testing (AST) determines the effectiveness of antibiotics or other antimicrobial drugs against microorganisms such as bacteria, fungi, and viruses. This testing method is an essential tool for guiding the selection of appropriate antibiotics used in treating infectious diseases and monitoring the emergence of drug-resistant strains of microorganisms. The market is experiencing growth due to various factors, including the rising incidence of infectious disorders, the growing adoption of point-of-care testing facilities, and the surging demand for prompt and precise detection of antibiotic resistance. However, challenges affecting the expansion of the AST market comprise high costs associated with advanced technologies such as molecular diagnostics instruments or automated systems, limiting their adoption by small-scale laboratories. In addition, limited access to robust healthcare infrastructure in developing countries, insufficient funding for research and development (R&D), lack of skilled professionals in the field, and variation in regulatory policies among different regions affecting market entry or expansion efforts are the additional obstacles affecting the expansion of the market. Additionally building partnerships between industry stakeholders such as diagnostic manufacturers, healthcare providers researchers and pharmaceutical companies can streamline processes while driving advancements in AST technologies. Moreover, the increasing demand for accurate and timely diagnosis of infectious diseases is expected to create lucrative opportunities for the market, particularly with the technological advancement in disease diagnosis testing techniques and the introduction of new genomic identification methods.

Regional Insights

The Americas and Europe are significant regions in the global antimicrobial susceptibility testing market due to the rise in infectious diseases and advanced healthcare infrastructure. The Centers for Disease Control and Prevention's National Healthcare Safety Network (NHSN), which tracks antimicrobial resistance patterns in nationwide healthcare facilities, promotes AST adoption while ensuring high-quality data collection. In Latin America, significant progress is observed in the field of antimicrobial susceptibility testing (AST), with countries such as Brazil adopting and executing guidelines established by the Clinical & Laboratory Standards Institute (CLSI). This crucial development contributes to the global efforts in combating antimicrobial resistance, thereby ensuring effective treatment options for bacterial infections. Furthermore, the European Centre for Disease Prevention and Control (ECDC) plays a pivotal role in tracking resistance patterns across Europe through its European Antimicrobial Resistance Surveillance Network (EARS-Net). The Asia-Pacific (APAC) is expected to experience substantial growth in the market due to rising awareness about infectious diseases, increasing healthcare expenditure, and emerging drug-resistant microorganisms. China, Japan, and India are the major markets for antimicrobial susceptibility testing within the Asia-Pacific. These nations have a high burden of infectious diseases and a large population, which is expected to drive the demand for AST products and services. Moreover, government initiatives worldwide to control infectious diseases and rising investments & funding in healthcare infrastructure are expected to bolster the market growth in the APAC.

Market Insights

• Market Dynamics
  
  The market dynamics represent an ever-changing landscape of the Antimicrobial Susceptibility Testing Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
  • Market Drivers
    • Importance of antimicrobial susceptibility testing in medical decision-making
    • Favorable government initiatives aiming to combat and prevent infectious diseases
    • Market Restraints
      • High cost of antimicrobial susceptibility kits and lack of skilled professionals
      • Market Opportunities
        • Ongoing research on nanoparticles-based antimicrobial susceptibility testing
        • Introduction of new genomic identification methods and launch of antimicrobial susceptibility test kits
        • Market Challenges
          • Incidence of product recalls and strict regulations regarding antimicrobial susceptibility testing commercialization
          • Market Segmentation Analysis
            • Product Type: Advancement in the automated tools and consumables for early diagnosing and treatment of the infectious diseases
            • Method: Development of qualitative AST techniques with increased accuracy of the tests
            • Type: Significant advancements in antifungal susceptibility testing due to heightened awareness of invasive fungal infections
            • Application: Rapid and extreme utilization of the AST in clinical diagnostics and drug discovery and development
            • End-User: Extensive use of AST in hospitals and diagnostic laboratories
            • Market Disruption Analysis
            • Porter’s Five Forces Analysis
            • Value Chain & Critical Path Analysis
            • Pricing Analysis
            • Technology Analysis
            • Patent Analysis
            • Trade Analysis
            • Regulatory Framework Analysis
            FPNV Positioning Matrix
            
            The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Antimicrobial Susceptibility Testing Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
            
            Market Share Analysis
            
            The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Antimicrobial Susceptibility Testing Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
            
            Recent Developments
            • Strathclyde spin-out Microplate dx secures GBP 2.5 million in funding
              
              Microplate Dx raised GBP 2.5 million (USD 3.11 million) in seed funding to advance the development of its innovative point-of-care diagnostic platform. The technology aims to quickly detect bacterial infections and guide physicians toward the most effective treatment options by rapidly identifying suitable antibiotics while avoiding ineffective ones. The platform merges novel hardware components with proprietary data processing algorithms to perform quick antibiotic susceptibility tests.
              
              Creative Diagnostics Announces New Antimicrobial Susceptibility Testing Services
              
              Creative Diagnostics has introduced its antimicrobial susceptibility testing (AST) services, aiming to support biotechnology and pharmaceutical researchers in detecting the sensitivity of test bacteria to antimicrobial drugs. The new AST services provide valuable insights into antibiotic treatment options and can be seamlessly integrated into Good Laboratory Practice (GLP) and Good Manufacturing Practice (GMP) environments, ensuring full traceability.
              
              Sysmex Launches World's First Point-of-Care Testing System in Europe to Detect Antimicrobial Susceptibility in Just 30 Minutes
              
              Sysmex Corporation introduced a point-of-care testing system for detecting antimicrobial susceptibility in Europe. The innovative system aims to expedite the diagnosis and treatment of urinary tract infections (UTIs) by using patient urine samples to detect bacterial presence and evaluate antimicrobial effectiveness. This rapid detection promotes the proper use of antimicrobials in primary care settings and contributes to combating antimicrobial resistance (AMR), a global challenge necessitating collaborative efforts.
            Strategy Analysis & Recommendation
            
            The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Antimicrobial Susceptibility Testing Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
            
            Key Company Profiles
            
            The report delves into recent significant developments in the Antimicrobial Susceptibility Testing Market, highlighting leading vendors and their innovative profiles. These include Accelerate Diagnostics, Inc., Alifax S.r.l., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., BIOANALYSE Tıbbi Malz. San. ve Tic. Ltd. Sti., BioMérieux SA, Biosafe Ltd., Bruker Corporation, Creative Diagnostics, Danaher Corporation, ELITech Group SAS, Erba Lachema s.r.o., Eurofins Scientific SE, F. Hoffmann-La Roche AG, Genefluidics, Inc., Himedia Laboratories Private Limited, INTEGRA Biosciences AG, Laboratorios Conda, S.A., Launch Diagnostics Limited, Leading Biology, Inc., Liofilchem S.r.l., Mast Group Ltd., MP Biomedicals, LLC, Pfizer Inc., Qiagen N.V., QuantaMatrix Inc., Rapid Test Methods Ltd., Resistell AG, Synoptics Group, Thermo Fisher Scientific Inc., and Zhuhai DL Biotech Co., Ltd..
            
            Market Segmentation & Coverage
            
            This research report categorizes the Antimicrobial Susceptibility Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:
            • Product Type
              • Automated Products
              • Consumables
              • Manual Products
                • Minimum Inhibitory Concentration (MIC) Strips
                • Susceptibility Discs
                • Susceptibility Plates
                • Method
                  • Agar Dilution
                  • Disks Diffusion
                  • ETEST
                  • Genotyping Methods
                  • Rapid Automation Method
                  • Type
                    • Antibacterial Susceptibility Testing
                    • Antifungal Susceptibility Testing
                    • Antiparasitic Susceptibility Testing
                    • Application
                      • Clinical Diagnostics
                      • Drug Discovery & Development
                      • Epidemiology
                      • End-User
                        • Contract Research Organizations
                        • Hospital & Diagnostic Centers
                        • Pharmaceutical & Biotechnology
                        • Research & Academic Institutes
                        • Region
                          • Americas
                            • Argentina
                            • Brazil
                            • Canada
                            • Mexico
                            • United States
                              • California
                              • Florida
                              • Illinois
                              • New York
                              • Ohio
                              • Pennsylvania
                              • Texas
                              • Asia-Pacific
                                • Australia
                                • China
                                • India
                                • Indonesia
                                • Japan
                                • Malaysia
                                • Philippines
                                • Singapore
                                • South Korea
                                • Taiwan
                                • Thailand
                                • Vietnam
                                • Europe, Middle East & Africa
                                  • Denmark
                                  • Egypt
                                  • Finland
                                  • France
                                  • Germany
                                  • Israel
                                  • Italy
                                  • Netherlands
                                  • Nigeria
                                  • Norway
                                  • Poland
                                  • Qatar
                                  • Russia
                                  • Saudi Arabia
                                  • South Africa
                                  • Spain
                                  • Sweden
                                  • Switzerland
                                  • Turkey
                                  • United Arab Emirates
                                  • United Kingdom
                                  
                                  
                                  Please Note: PDF & Excel + Online Access - 1 Year